-
PROVIDERS
REGISTER NOW
Navigating new frontiers in breast cancer care pathway intelligence: The role of providers and AI
Tuesday, July 29th
2:00pm PT, 4:00pm CT, 5:00pm ET -
LIFE SCIENCES
REGISTER NOW
Closing Care Gaps with AI: The Next Competitive Edge in Pharma
Monday, July 14
9am PT, 11am CT, 12pm ET -
PATIENTS
It's About Time
View the Tempus vision.
- RESOURCES
-
ABOUT US
View Job Postings
We’re looking for people who can change the world.
- INVESTORS
TEMPUS GENE LIBRARY
This gene overview is brought to you as part of Tempus’ goal to inform providers about our genomic testing panels and the genes included in our offerings. Through our robust de-identified database of clinical information coupled with molecular testing results, we are capable of providing unique insights into these gene alterations. Many of the gene alterations reported on our somatic and germline panels are often key inclusion criteria for clinical trials.
ATM Gene
A-T MutatedThe ATM gene is a member of the PI3/PI4-kinase gene family. The ATM gene functions as a cell cycle checkpoint kinase, controlling the rate of cell growth and division. Additionally, it assists in the repair of damaged DNA. Loss of function mutations, copy number loss, and underexpression of ATM are associated with cancer progression.
ATM alterations in 10 most common cancers – Tempus database
FDA approved drugs for ATM mutated cancers
| Therapy | Tumor type (indication) | Biomarker |
|---|---|---|
| LYNPARZA® olaparib | Prostate cancer | HRR genes including ATM |
Some strategies in clinical development targeting ATM pathway
| Mechanism | Phase 1 | Phase 2 |
|---|---|---|
| MDM2 inhibitor | APG-115 | |
| PARP inhibitor | talazoparib (BMN 673) niraparib (MK-4827) | |
| CHK1 inhibitor | prexasertib (LY2606368) | |
| ATR Inhibitor | M4344 (VX-803) | M6620 (VX-970) ceralasertib (AZD6738) |
| ATM inhibitor | AZD1390 | |
| Immunotherapy | nivolumab ipilimumab HX008 pembrolizumab |
View a more comprehensive list of clinical trials for patients with ATM mutated cancers. The Tempus TIME Trial ® Program brings the right clinical trial options directly to patients, for enrollment at your institution. Learn more
Additional resources for ATM gene:
Additional resources on variants:
Join the movement
We are committed to helping advance cancer treatment for patients. We believe that every new test is an investment in the development of patient care for the future.